MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
GoodRx Holdings Operating Income 2011-2026 | GDRX
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income GoodRx Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65.8 M | -27 M | 1.74 M | 13.4 M | -276 M | 140 M | 77.3 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 140 M | -276 M | -687 K |
Quarterly Operating Income GoodRx Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.6 M | 26.8 M | 23.4 M | 20.4 M | 19.9 M | 7.38 M | -38.3 M | 18.3 M | 11.3 M | - | -15.7 M | -4.05 M | 19.8 M | - | 7 M | -351 K | -5 M | - | -61.7 M | 41.7 M | 43.7 M | - | 37.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 43.7 M | -61.7 M | 8.79 M |
Operating Income of other stocks in the Health information services industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-46.8 M | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
708 M | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
-42.6 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
-23 M | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
137 M | - | - | $ 9.03 B | USA |
 |
iCAD
ICAD
|
-6.27 M | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
3.64 M | $ 2.52 | -0.59 % | $ 236 M | USA |
 |
SCWorx Corp.
WORX
|
-959 K | - | - | $ 7.71 M | USA |
 |
Akerna Corp.
KERN
|
-228 M | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
77.2 M | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
11.3 M | - | -0.58 % | $ 51.7 M | USA |
 |
NextGen Healthcare
NXGN
|
12.8 M | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
-243 M | - | - | $ 3.37 B | USA |
 |
10x Genomics
TXG
|
-265 M | $ 24.6 | 4.33 % | $ 2.88 B | USA |
 |
OptimizeRx Corporation
OPRX
|
-26.4 M | $ 5.95 | 0.34 % | $ 102 M | USA |
 |
Health Catalyst
HCAT
|
-161 M | $ 1.1 | 3.3 % | $ 76.9 M | USA |
 |
HealthEquity
HQY
|
322 M | $ 80.27 | 0.45 % | $ 6.91 B | USA |
 |
Premier
PINC
|
1.12 M | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
-167 M | $ 11.79 | 2.97 % | $ 866 M | USA |
 |
Phreesia
PHR
|
-6.61 M | $ 8.6 | 0.47 % | $ 514 M | USA |
 |
R1 RCM
RCM
|
146 M | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
-263 M | $ 5.22 | - | $ 920 M | USA |
 |
Signify Health
SGFY
|
9.5 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-8.03 M | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
-51.3 M | - | -46.64 % | $ 10.4 M | USA |
 |
American Well Corporation
AMWL
|
-105 M | $ 5.47 | -1.44 % | $ 87.8 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-69 M | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
21.3 M | $ 20.49 | 0.59 % | $ 623 M | USA |
 |
Omnicell
OMCL
|
337 K | $ 36.28 | 3.61 % | $ 1.67 B | USA |
 |
Progyny
PGNY
|
15.8 M | $ 16.86 | -0.68 % | $ 1.45 B | USA |
 |
So-Young International
SY
|
-624 M | $ 2.75 | 2.23 % | $ 218 M |  China |
 |
Veeva Systems
VEEV
|
916 M | $ 157.03 | -0.9 % | $ 25.7 B | USA |
 |
Zhongchao
ZCMD
|
-6.19 M | $ 1.99 | -1.24 % | $ 6.8 M | China |